Repository logo
Communities & Collections
All of UMU-IR
  • English
  • العربية
  • বাংলা
  • Català
  • Čeština
  • Deutsch
  • Ελληνικά
  • Español
  • Suomi
  • Français
  • Gàidhlig
  • हिंदी
  • Magyar
  • Italiano
  • Қазақ
  • Latviešu
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Srpski (lat)
  • Српски
  • Svenska
  • Türkçe
  • Yкраї́нська
  • Tiếng Việt
Log In
New user? Click here to register. Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Acheng Miriam"

Filter results by typing the first few letters
Now showing 1 - 1 of 1
  • Results Per Page
  • Sort Options
  • No Thumbnail Available
    Item
    Multi-level determinants of tuberculosis treatment completion in rural Uganda:
    (Plos One, 2026-04-20) Turyasiima Munanura; Muliika Daniel; Turinawe Gaston; Acheng Miriam; Ikiriza Antony; Alinde Agnes; Natureeba Precious; Nkwasiimwe Amon; Akot Balbina Gillian; Kayizi Susan Wandera Wendy; Asasira Derrick; Nantege Shamim; Oode Iliot Daniel; Wesonga Hilda Barbra; Atuhaire Raymond Kamara; Kooko Ronald
    Background Tuberculosis (TB) treatment completion rates in high-burden countries like Uganda often fall short of the WHO End TB Strategy target of ≥90%. This study evaluated multilevel determinants of treatment completion to guide evidence-based improvement strategies in rural Western Uganda. Methods We conducted a cross-sectional, multi-center analytical study of 224 patients with drug-susceptible TB across four public health facilities in Kakumiro District. Eligible participants had been on treatment for at least six months. Data collected via structured questionnaires were validated against facility TB registers. Multivariable logistic regression identified independent predictors, reported as adjusted odds ratios (AOR) with 95% confidence intervals (CI). Results The treatment completion rate was 82.6% (185/224), with a 30.4% TB-HIV co-infection rate. Significant positive predictors included high TB knowledge (AOR = 14.0; 95% CI: 3.06–24.5), high economic status (AOR = 7.2; 95% CI: 1.63–31.5), belief in treatment efficacy (AOR = 6.2; 95% CI: 2.02–18.8), and respectful health worker behavior (AOR = 5.0; 95% CI: 2.15–11.83). Community-level support was critical, specifically religious/community leader advocacy (AOR = 4.2; 95% CI: 1.84–9.51) and community health worker (CHW) home visits (AOR = 3.5; 95% CI: 1.64–7.72). Waiting time less than 30 minutes (AOR = 6.3, 95% CI: 1.91–20.96) also positively impacted TB treatment completion. Major negative predictors were male gender (AOR = 0.3; 95% CI: 0.11–0.86), drug stockouts (AOR = 0.3; 95% CI: 0.11–0.70), belief in traditional cures (AOR = 0.3; 95% CI: 0.13–0.71), and stigma (AOR = 0.4; 95% CI: 0.16–0.80). Conclusion Achieving the WHO End TB targets requires integrated, multilevel interventions. Efforts should focus on male-targeted engagement, strengthening supply chains to eliminate drug stockouts, enhancing CHW-led community outreach, and reducing stigma to ensure equitable treatment success

Uganda Martyrs University copyright ©2026 LYRASIS

  • Privacy policy
  • End User Agreement
  • Send Feedback